ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 662253 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 662253; 2) Community: the network communities that were significantly associated with the response to NSC 662253; 3) Molecule: the relationships between components within communities and NSC 662253; 4) MDR: the compounds that were significantly associated with the NSC 662253.

NSC Compound Enrichment Correlation
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0178844438004195 0.30017723
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.0178844438004195 0.18139847
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0178844438004195 0.23517182
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0178844438004195 0.18323691
NSC 759274 ARSENIC TRIOXIDE 0.0178844438004195 0.29390939
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0178844438004195 0.43753918
NSC 87500 Solacongestidine 0.0178844438004195 0.26868798
NSC 93354 Null 0.0178844438004195 0.118595
NSC 669229 2-trans-n-buten-1-yl-estradiol 0.0179905510964914 -0.045441632
NSC 673824 Null 0.0179905510964914 0.038104031
Total:146  Current:75    [First] [Prev] [Next] [Last]